As Charles Krauthammer and David Brooks have already noted, this campaign season has been marked by an unusual degree of Democratic self-delusion. Everything is to be blamed for the current plight of the party except its elected leaders and the policies they have pursued while in office. Thus, the reason Democrats are headed for an electoral drubbing is that secret corporate money has distorted our democratic processes. Or if not that, then because voters can no longer hear the truth through all the misleading clutter spouted by the right-leaning media. Or perhaps because the electorate is just too dim to realize how important and positive the Democratic agenda has been for them and the country.
The self-delusion seems particularly acute when the conversation turns to health care. Democrats and their media apologists just can’t bring themselves to believe that there is anything substantive behind opposition to Obamacare. And so, instead of engaging in serious argument, they offer up condescending nonsense — such as this New York Times editorial, which supposedly debunks the myths being peddled on the campaign trail by candidates trying to stir up opposition to Obamacare.
The Times piece begins by calling “pure nonsense” the suggestion by Senate candidate John Raese that Obamacare will force some patients to go through a bureaucrat or a panel to reach a doctor. And, of course, it’s true that the new law does not have an explicit provision which puts a bureaucrat in charge of physician access for all Americans.
But Obamacare does create the Independent Payment Advisory Board, or IPAB, which has the potential to become a very powerful hurdle to certain types of care. Under the new law, the 15-member IPAB has the authority to implement cost-cutting mechanisms in Medicare without further congressional approval. Indeed, IPAB’s proponents have been quite explicit in their hope that the panel will use government-funded “comparative-effectiveness research” as the basis to terminate Medicare reimbursement for items and services deemed not “cost effective” by budget cutters. So, here we have an unelected board of so-called experts with the authority to unilaterally decide that certain treatments should not be funded by Medicare. Only the most blinded enthusiasts of governmental activism don’t see the potential problems with this approach, or understand the legitimate fears that it creates in the electorate.
Moreover, the Medicare Advantage cuts will fall disproportionately on low-income and minority seniors who don’t have access to a retiree wraparound plan and can’t afford Medigap coverage. For them, the lower cost-sharing offered by Medicare Advantage plans is instrumental in helping them afford the care they need.
Of course, the Times editorial doesn’t even address the main reason voters are so upset that Obamacare was jammed through Congress. The public knows and understands that federal finances are on the brink of meltdown. The federal government is running trillion-dollar deficits as far as the eye can see, and there is no serious plan to get things under control. And, in fact, the signature initiative of the Obama administration was to pile another massive entitlement on top of the unaffordable ones already on the books, and partially pay for it with a $700 billion tax increase when unemployment is already running near 10 percent. The voters see all of this, and understand it perfectly well. What we have here is a Democratic president and a Democratic Congress that could not help themselves. They saw an opportunity to enact what liberals have been dreaming of for decades, and they decided it was more important to lock that in than to work with Republicans on reviving the economy.
And for that misplacement of priorities the voters will be holding them accountable next week.